Fmr LLC Bei Gene, Ltd. Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Fmr LLC holds 1,647,156 shares of BGNE stock, worth $341 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,647,156

Previous 1,680,463 1.98%

Holding current value

$341 Million

Previous $263 Million 10.58%

% of portfolio

0.02%

Previous 0.02%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$129.52 - $174.32 $4.31 Million - $5.81 Million	-33,307 Reduced 1.98%	1,647,156 $235 Million
Q1 2024 May 13, 2024	SELL	$141.8 - $181.47 $5.79 Million - $7.41 Million	-40,840 Reduced 2.37%	1,680,463 $263 Million
Q4 2023 Feb 13, 2024	SELL	$158.67 - $201.58 $100 Million - $127 Million	-631,427 Reduced 26.84%	1,721,303 $310 Million
Q3 2023 Nov 13, 2023	BUY	$179.87 - $225.13 $12.5 Million - $15.6 Million	69,297 Added 3.03%	2,352,730 $423 Million
Q2 2023 Aug 11, 2023	SELL	$178.3 - $266.78 $38.7 Million - $57.9 Million	-216,923 Reduced 8.68%	2,283,433 $407 Million
Q1 2023 May 11, 2023	SELL	$215.53 - $274.5 $35.2 Million - $44.8 Million	-163,369 Reduced 6.13%	2,500,356 $539 Million
Q4 2022 Feb 13, 2023	BUY	$125.51 - $229.3 $7.2 Million - $13.1 Million	57,335 Added 2.2%	2,663,725 $586 Million
Q3 2022 Nov 10, 2022	SELL	$131.8 - $202.24 $37.7 Million - $57.9 Million	-286,373 Reduced 9.9%	2,606,390 $351 Million
Q2 2022 Aug 12, 2022	SELL	$121.11 - $216.05 $63.1 Million - $113 Million	-520,874 Reduced 15.26%	2,892,763 $468 Million
Q1 2022 May 13, 2022	SELL	$146.52 - $269.56 $31 Million - $57.1 Million	-211,696 Reduced 5.84%	3,413,637 $644 Million
Q4 2021 Feb 14, 2022	SELL	$248.56 - $389.34 $46.4 Million - $72.7 Million	-186,667 Reduced 4.9%	3,625,333 $982 Million
Q3 2021 Nov 15, 2021	SELL	$249.6 - $403.14 $119 Million - $193 Million	-478,468 Reduced 11.15%	3,812,000 $1.38 Billion
Q2 2021 Aug 13, 2021	BUY	$292.75 - $367.01 $1.26 Billion - $1.57 Billion	4,290,468 New	4,290,468 $1.47 Billion

Others Institutions Holding BGNE

# of Institutions

219

Shares Held

42.1M

Call Options Held

106K

Put Options Held

93.1K

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $21.4B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account